Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

NCT04861103 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Pregnancy, High Risk
Anticoagulants

Interventions

DRUG: Lovenox

Sponsor

University of California, Irvine